空カプセル市場(供給源:豚由来、牛由来、海洋由来、天然由来;およびタイプ:ゼラチンカプセルと非ゼラチンカプセル)-世界産業分析、規模、シェア、成長、動向、予測、2023-2031年Empty Capsules Market (Source: Porcine, Bovine, Marine, and Natural; and Type: Gelatin Capsules and Non-gelatin Capsules) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031 空カプセル市場 - レポートの範囲 TMRの空カプセルの世界市場に関する調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー空カプセル市場 - レポートの範囲TMRの空カプセルの世界市場に関する調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会を調査しています。本レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの世界の空カプセルの市場収益を提供しています。また、2023年から2031年までの世界の空カプセル市場の複合年間成長率(CAGR %)も掲載しています。 本レポートは広範な調査を経て作成されました。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書を参照し、空カプセル市場を理解しました。 二次調査にはインターネット情報源、政府機関の統計データ、ウェブサイト、業界団体なども含まれた。アナリストは、世界の空カプセルの様々な属性を調査するために、トップダウンアプローチとボトムアップアプローチの組み合わせを採用しました。 本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、このレポートは世界の空カプセル市場における競争力学の変化に光を投げかけています。これらは、既存の市場プレーヤーだけでなく、世界の空カプセル市場への参入に関心のある事業体にとっても貴重なツールとなります。 本レポートは、世界の空カプセルの競争状況について掘り下げています。世界の空カプセル市場で事業を展開する主要企業が特定され、これらの各企業が様々な属性でプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の空カプセル市場のプレーヤーの属性です。 空のカプセルの世界市場レポートで回答された主な質問 - 予測期間中の全地域における空カプセルの売上高/収益は? - 世界の空カプセルの市場における機会は何か? - 市場における主な促進要因、阻害要因、機会、脅威は何か? - 予測期間中に最も速いCAGRで拡大する地域市場はどこか? - 2031年に世界で最も高い収益を上げると予測されるセグメントは? - 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは? - 世界市場で事業を展開する各企業の市場ポジションは? 空カプセル市場 - 調査目的と調査アプローチ 空のカプセルの世界市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーと流通業者、製品の承認に関する規制シナリオについて詳しく解説しています。 本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフや表が適切に散りばめられた網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴える。また、過去と予測期間末の主要セグメントの市場シェアを比較することもできる。 本レポートでは、世界の空カプセル市場を製品、エンドユーザー、地域の観点から分析しています。各基準の主要セグメントを詳細に調査し、2031年末時点での各セグメントごとの市場シェアを掲載しています。このような貴重な洞察は、市場関係者が世界の空カプセル市場への投資のための情報に基づいたビジネス上の意思決定を行うことを可能にします。 目次1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumption and Research Methodology 3. Executive Summary: Global Empty Capsules Market 4. Market Overview 4.1. Introduction 4.1.1. Segment Definition 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Empty Capsules Market Analysis and Forecast, 2017 - 2031 4.4.1. Market Revenue Projections (US$ Mn) 5. Key Insights 5.1. Porter’s Five Force Analysis 5.2. Regulation of Dietary Supplements, by Country 5.3. Innovation in Capsule Technology 5.4. Key Industry Events 5.5. COVID-19 Pandemic Impact on Industry 6. Global Empty Capsules Market Analysis and Forecast, by Source 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast by Source, 2017 - 2031 6.3.1. Porcine 6.3.2. Bovine 6.3.3. Marine 6.3.4. Natural 6.4. Market Attractiveness by Source 7. Global Empty Capsules Market Analysis and Forecast, by Type 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast by Type, 2017 - 2031 7.3.1. Gelatin Capsules 7.3.1.1. Hard Gelatin Capsules 7.3.1.2. Soft Gelatin Capsules 7.3.2. Non-gelatin Capsules 7.4. Market Attractiveness by Type 8. Global Empty Capsules Market Analysis and Forecast, by Functionality 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Market Value Forecast by Functionality, 2017 - 2031 8.3.1. Immediate Release 8.3.2. Sustained Release 8.3.3. Delayed Release 8.4. Market Attractiveness by Functionality 9. Global Empty Capsules Market Analysis and Forecast, by Application 9.1. Introduction & Definition 9.2. Key Findings / Developments 9.3. Market Value Forecast by Application, 2017 - 2031 9.3.1. Antibiotic & Antibacterial Drugs 9.3.2. Dietary Supplements 9.3.3. Antacid & Antiflatulent Preparations 9.3.4. Cardiovascular Therapy Drugs 9.3.5. Cough & Cold Drugs 9.3.6. Others (Antianemic Preparations, Anti-inflammatory Drugs, etc.) 9.4. Market Attractiveness by Application 10. Global Empty Capsules Market Analysis and Forecast, by End-user 10.1. Introduction & Definition 10.2. Key Findings / Developments 10.3. Market Value Forecast by End-user, 2017 - 2031 10.3.1. Pharmaceutical & Biopharmaceutical Companies 10.3.2. Nutraceutical Companies 10.3.3. Others 10.4. Market Attractiveness by End-user 11. Global Empty Capsules Market Analysis and Forecast, by Region 11.1. Key Findings 11.2. Market Value Forecast by Region 11.2.1. North America 11.2.2. Europe 11.2.3. Asia Pacific 11.2.4. Latin America 11.2.5. Middle East & Africa 11.3. Market Attractiveness by Country/Region 12. North America Empty Capsules Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast by Source, 2017 - 2031 12.2.1. Porcine 12.2.2. Bovine 12.2.3. Marine 12.2.4. Natural 12.3. Market Value Forecast by Type, 2017 - 2031 12.3.1. Gelatin Capsules 12.3.1.1. Hard Gelatin Capsules 12.3.1.2. Soft Gelatin Capsules 12.3.2. Non-gelatin Capsules 12.4. Market Value Forecast by Functionality, 2017 - 2031 12.4.1. Immediate Release 12.4.2. Sustained Release 12.4.3. Delayed Release 12.5. Market Value Forecast by Application, 2017 - 2031 12.5.1. Antibiotic & Antibacterial Drugs 12.5.2. Dietary Supplements 12.5.3. Antacid & Antiflatulent Preparations 12.5.4. Cardiovascular Therapy Drugs 12.5.5. Cough & Cold Drugs 12.5.6. Others (Antianemic Preparations, Anti-inflammatory Drugs, etc.) 12.6. Market Value Forecast by End-User, 2017 - 2031 12.6.1. Pharmaceutical & Biopharmaceutical Companies 12.6.2. Nutraceutical Companies 12.6.3. Others 12.7. Market Value Forecast by Country, 2017 - 2031 12.7.1. U.S. 12.7.2. Canada 12.8. Market Attractiveness Analysis 12.8.1. by Source 12.8.2. by Type 12.8.3. by Functionality 12.8.4. by Application 12.8.5. by End-user 12.8.6. by Country 13. Europe Empty Capsules Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast by Source, 2017 - 2031 13.2.1. Porcine 13.2.2. Bovine 13.2.3. Marine 13.2.4. Natural 13.3. Market Value Forecast by Type, 2017 - 2031 13.3.1. Gelatin Capsules 13.3.1.1. Hard Gelatin Capsules 13.3.1.2. Soft Gelatin Capsules 13.3.2. Non-gelatin Capsules 13.4. Market Value Forecast by Functionality, 2017 - 2031 13.4.1. Immediate Release 13.4.2. Sustained Release 13.4.3. Delayed Release 13.5. Market Value Forecast by Application, 2017 - 2031 13.5.1. Antibiotic & Antibacterial Drugs 13.5.2. Dietary Supplements 13.5.3. Antacid & Antiflatulent Preparations 13.5.4. Cardiovascular Therapy Drugs 13.5.5. Cough & Cold Drugs 13.5.6. Others (Antianemic Preparations, Anti-inflammatory Drugs, etc.) 13.6. Market Value Forecast by End-User, 2017 - 2031 13.6.1. Pharmaceutical & Biopharmaceutical Companies 13.6.2. Nutraceutical Companies 13.6.3. Others 13.7. Market Value Forecast by Country/Sub-region, 2017 - 2031 13.7.1. Germany 13.7.2. U.K. 13.7.3. France 13.7.4. Italy 13.7.5. Spain 13.7.6. Rest of Europe 13.8. Market Attractiveness Analysis 13.8.1. by Source 13.8.2. by Type 13.8.3. by Functionality 13.8.4. by Application 13.8.5. by End-user 13.8.6. by Country/Sub-region 14. Asia Pacific Empty Capsules Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast by Source, 2017 - 2031 14.2.1. Porcine 14.2.2. Bovine 14.2.3. Marine 14.2.4. Natural 14.3. Market Value Forecast by Type, 2017 - 2031 14.3.1. Gelatin Capsules 14.3.1.1. Hard Gelatin Capsules 14.3.1.2. Soft Gelatin Capsules 14.3.2. Non-gelatin Capsules 14.4. Market Value Forecast by Functionality, 2017 - 2031 14.4.1. Immediate Release 14.4.2. Sustained Release 14.4.3. Delayed Release 14.5. Market Value Forecast by Application, 2017 - 2031 14.5.1. Antibiotic & Antibacterial Drugs 14.5.2. Dietary Supplements 14.5.3. Antacid & Antiflatulent Preparations 14.5.4. Cardiovascular Therapy Drugs 14.5.5. Cough & Cold Drugs 14.5.6. Others (Antianemic Preparations, Anti-inflammatory Drugs, etc.) 14.6. Market Value Forecast by End-user, 2017 - 2031 14.6.1. Pharmaceutical & Biopharmaceutical Companies 14.6.2. Nutraceutical Companies 14.6.3. Others 14.7. Market Value Forecast by Country/Sub-region, 2017 - 2031 14.7.1. China 14.7.2. Japan 14.7.3. India 14.7.4. Australia & New Zealand 14.7.5. Rest of Asia Pacific 14.8. Market Attractiveness Analysis 14.8.1. by Source 14.8.2. by Type 14.8.3. by Functionality 14.8.4. by Application 14.8.5. by End-user 14.8.6. by Country/Sub-region 15. Latin America Empty Capsules Market Analysis and Forecast 15.1. Introduction 15.1.1. Key Findings 15.2. Market Value Forecast by Source, 2017 - 2031 15.2.1. Porcine 15.2.2. Bovine 15.2.3. Marine 15.2.4. Natural 15.3. Market Value Forecast by Type, 2017 - 2031 15.3.1. Gelatin Capsules 15.3.1.1. Hard Gelatin Capsules 15.3.1.2. Soft Gelatin Capsules 15.3.2. Non-gelatin Capsules 15.4. Market Value Forecast by Functionality, 2017 - 2031 15.4.1. Immediate Release 15.4.2. Sustained Release 15.4.3. Delayed Release 15.5. Market Value Forecast by Application, 2017 - 2031 15.5.1. Antibiotic & Antibacterial Drugs 15.5.2. Dietary Supplements 15.5.3. Antacid & Antiflatulent Preparations 15.5.4. Cardiovascular Therapy Drugs 15.5.5. Cough & Cold Drugs 15.5.6. Others (Antianemic Preparations, Anti-inflammatory Drugs, etc.) 15.6. Market Value Forecast by End-user, 2017 - 2031 15.6.1. Pharmaceutical & Biopharmaceutical Companies 15.6.2. Nutraceutical Companies 15.6.3. Others 15.7. Market Value Forecast by Country/Sub-region, 2017 - 2031 15.7.1. Brazil 15.7.2. Mexico 15.7.3. Rest of Latin America 15.8. Market Attractiveness Analysis 15.8.1. by Source 15.8.2. by Type 15.8.3. by Functionality 15.8.4. by Application 15.8.5. by End-user 15.8.6. by Country/Sub-region 16. Middle East & Africa Empty Capsules Market Analysis and Forecast 16.1. Introduction 16.1.1. Key Findings 16.2. Market Value Forecast by Source, 2017 - 2031 16.2.1. Porcine 16.2.2. Bovine 16.2.3. Marine 16.2.4. Natural 16.3. Market Value Forecast by Type, 2017 - 2031 16.3.1. Gelatin Capsules 16.3.1.1. Hard Gelatin Capsules 16.3.1.2. Soft Gelatin Capsules 16.3.2. Non-gelatin Capsules 16.4. Market Value Forecast by Functionality, 2017 - 2031 16.4.1. Immediate Release 16.4.2. Sustained Release 16.4.3. Delayed Release 16.5. Market Value Forecast by Application, 2017 - 2031 16.5.1. Antibiotic & Antibacterial Drugs 16.5.2. Dietary Supplements 16.5.3. Antacid & Antiflatulent Preparations 16.5.4. Cardiovascular Therapy Drugs 16.5.5. Cough & Cold Drugs 16.5.6. Others (Antianemic Preparations, Anti-inflammatory Drugs, etc.) 16.6. Market Value Forecast by End-user, 2017 - 2031 16.6.1. Pharmaceutical & Biopharmaceutical Companies 16.6.2. Nutraceutical Companies 16.6.3. Others 16.7. Market Value Forecast by Country/Sub-region, 2017 - 2031 16.7.1. GCC Countries 16.7.2. South Africa 16.7.3. Rest of Middle East & Africa 16.8. Market Attractiveness Analysis 16.8.1. by Source 16.8.2. by Type 16.8.3. by Functionality 16.8.4. by Application 16.8.5. by End-user 16.8.6. by Country/Sub-region 17. Competition Landscape 17.1. Market Player - Competition Matrix (by Tier and Size of companies) 17.2. Market Share Analysis by Company (2022) 17.3. Company Profiles 17.3.1. ACG 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.1.2. Product Portfolio 17.3.1.3. Financial Overview 17.3.1.4. SWOT Analysis 17.3.1.5. Strategic Overview 17.3.2. Lonza Group Ltd. 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.2.2. Product Portfolio 17.3.2.3. Financial Overview 17.3.2.4. SWOT Analysis 17.3.2.5. Strategic Overview 17.3.3. Qualicaps (Mitsubishi Chemical Group Corporation) 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.3.2. Product Portfolio 17.3.3.3. Financial Overview 17.3.3.4. SWOT Analysis 17.3.3.5. Strategic Overview 17.3.4. Seoheung Co., Ltd. 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.4.2. Product Portfolio 17.3.4.3. Financial Overview 17.3.4.4. SWOT Analysis 17.3.4.5. Strategic Overview 17.3.5. The Roxlor Group 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.5.2. Product Portfolio 17.3.5.3. Financial Overview 17.3.5.4. SWOT Analysis 17.3.5.5. Strategic Overview 17.3.6. Nectar Lifesciences Ltd 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.6.2. Product Portfolio 17.3.6.3. Financial Overview 17.3.6.4. SWOT Analysis 17.3.6.5. Strategic Overview 17.3.7. Medi-Caps Ltd. 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.7.2. Product Portfolio 17.3.7.3. Financial Overview 17.3.7.4. SWOT Analysis 17.3.7.5. Strategic Overview 17.3.8. CapsCanada 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.8.2. Product Portfolio 17.3.8.3. Financial Overview 17.3.8.4. SWOT Analysis 17.3.8.5. Strategic Overview 17.3.9. Natural Capsules Limited 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.9.2. Product Portfolio 17.3.9.3. Financial Overview 17.3.9.4. SWOT Analysis 17.3.9.5. Strategic Overview
SummaryEmpty Capsules Market – Scope of Report Table of Contents1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumption and Research Methodology 3. Executive Summary: Global Empty Capsules Market 4. Market Overview 4.1. Introduction 4.1.1. Segment Definition 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Empty Capsules Market Analysis and Forecast, 2017 - 2031 4.4.1. Market Revenue Projections (US$ Mn) 5. Key Insights 5.1. Porter’s Five Force Analysis 5.2. Regulation of Dietary Supplements, by Country 5.3. Innovation in Capsule Technology 5.4. Key Industry Events 5.5. COVID-19 Pandemic Impact on Industry 6. Global Empty Capsules Market Analysis and Forecast, by Source 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast by Source, 2017 - 2031 6.3.1. Porcine 6.3.2. Bovine 6.3.3. Marine 6.3.4. Natural 6.4. Market Attractiveness by Source 7. Global Empty Capsules Market Analysis and Forecast, by Type 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast by Type, 2017 - 2031 7.3.1. Gelatin Capsules 7.3.1.1. Hard Gelatin Capsules 7.3.1.2. Soft Gelatin Capsules 7.3.2. Non-gelatin Capsules 7.4. Market Attractiveness by Type 8. Global Empty Capsules Market Analysis and Forecast, by Functionality 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Market Value Forecast by Functionality, 2017 - 2031 8.3.1. Immediate Release 8.3.2. Sustained Release 8.3.3. Delayed Release 8.4. Market Attractiveness by Functionality 9. Global Empty Capsules Market Analysis and Forecast, by Application 9.1. Introduction & Definition 9.2. Key Findings / Developments 9.3. Market Value Forecast by Application, 2017 - 2031 9.3.1. Antibiotic & Antibacterial Drugs 9.3.2. Dietary Supplements 9.3.3. Antacid & Antiflatulent Preparations 9.3.4. Cardiovascular Therapy Drugs 9.3.5. Cough & Cold Drugs 9.3.6. Others (Antianemic Preparations, Anti-inflammatory Drugs, etc.) 9.4. Market Attractiveness by Application 10. Global Empty Capsules Market Analysis and Forecast, by End-user 10.1. Introduction & Definition 10.2. Key Findings / Developments 10.3. Market Value Forecast by End-user, 2017 - 2031 10.3.1. Pharmaceutical & Biopharmaceutical Companies 10.3.2. Nutraceutical Companies 10.3.3. Others 10.4. Market Attractiveness by End-user 11. Global Empty Capsules Market Analysis and Forecast, by Region 11.1. Key Findings 11.2. Market Value Forecast by Region 11.2.1. North America 11.2.2. Europe 11.2.3. Asia Pacific 11.2.4. Latin America 11.2.5. Middle East & Africa 11.3. Market Attractiveness by Country/Region 12. North America Empty Capsules Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast by Source, 2017 - 2031 12.2.1. Porcine 12.2.2. Bovine 12.2.3. Marine 12.2.4. Natural 12.3. Market Value Forecast by Type, 2017 - 2031 12.3.1. Gelatin Capsules 12.3.1.1. Hard Gelatin Capsules 12.3.1.2. Soft Gelatin Capsules 12.3.2. Non-gelatin Capsules 12.4. Market Value Forecast by Functionality, 2017 - 2031 12.4.1. Immediate Release 12.4.2. Sustained Release 12.4.3. Delayed Release 12.5. Market Value Forecast by Application, 2017 - 2031 12.5.1. Antibiotic & Antibacterial Drugs 12.5.2. Dietary Supplements 12.5.3. Antacid & Antiflatulent Preparations 12.5.4. Cardiovascular Therapy Drugs 12.5.5. Cough & Cold Drugs 12.5.6. Others (Antianemic Preparations, Anti-inflammatory Drugs, etc.) 12.6. Market Value Forecast by End-User, 2017 - 2031 12.6.1. Pharmaceutical & Biopharmaceutical Companies 12.6.2. Nutraceutical Companies 12.6.3. Others 12.7. Market Value Forecast by Country, 2017 - 2031 12.7.1. U.S. 12.7.2. Canada 12.8. Market Attractiveness Analysis 12.8.1. by Source 12.8.2. by Type 12.8.3. by Functionality 12.8.4. by Application 12.8.5. by End-user 12.8.6. by Country 13. Europe Empty Capsules Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast by Source, 2017 - 2031 13.2.1. Porcine 13.2.2. Bovine 13.2.3. Marine 13.2.4. Natural 13.3. Market Value Forecast by Type, 2017 - 2031 13.3.1. Gelatin Capsules 13.3.1.1. Hard Gelatin Capsules 13.3.1.2. Soft Gelatin Capsules 13.3.2. Non-gelatin Capsules 13.4. Market Value Forecast by Functionality, 2017 - 2031 13.4.1. Immediate Release 13.4.2. Sustained Release 13.4.3. Delayed Release 13.5. Market Value Forecast by Application, 2017 - 2031 13.5.1. Antibiotic & Antibacterial Drugs 13.5.2. Dietary Supplements 13.5.3. Antacid & Antiflatulent Preparations 13.5.4. Cardiovascular Therapy Drugs 13.5.5. Cough & Cold Drugs 13.5.6. Others (Antianemic Preparations, Anti-inflammatory Drugs, etc.) 13.6. Market Value Forecast by End-User, 2017 - 2031 13.6.1. Pharmaceutical & Biopharmaceutical Companies 13.6.2. Nutraceutical Companies 13.6.3. Others 13.7. Market Value Forecast by Country/Sub-region, 2017 - 2031 13.7.1. Germany 13.7.2. U.K. 13.7.3. France 13.7.4. Italy 13.7.5. Spain 13.7.6. Rest of Europe 13.8. Market Attractiveness Analysis 13.8.1. by Source 13.8.2. by Type 13.8.3. by Functionality 13.8.4. by Application 13.8.5. by End-user 13.8.6. by Country/Sub-region 14. Asia Pacific Empty Capsules Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast by Source, 2017 - 2031 14.2.1. Porcine 14.2.2. Bovine 14.2.3. Marine 14.2.4. Natural 14.3. Market Value Forecast by Type, 2017 - 2031 14.3.1. Gelatin Capsules 14.3.1.1. Hard Gelatin Capsules 14.3.1.2. Soft Gelatin Capsules 14.3.2. Non-gelatin Capsules 14.4. Market Value Forecast by Functionality, 2017 - 2031 14.4.1. Immediate Release 14.4.2. Sustained Release 14.4.3. Delayed Release 14.5. Market Value Forecast by Application, 2017 - 2031 14.5.1. Antibiotic & Antibacterial Drugs 14.5.2. Dietary Supplements 14.5.3. Antacid & Antiflatulent Preparations 14.5.4. Cardiovascular Therapy Drugs 14.5.5. Cough & Cold Drugs 14.5.6. Others (Antianemic Preparations, Anti-inflammatory Drugs, etc.) 14.6. Market Value Forecast by End-user, 2017 - 2031 14.6.1. Pharmaceutical & Biopharmaceutical Companies 14.6.2. Nutraceutical Companies 14.6.3. Others 14.7. Market Value Forecast by Country/Sub-region, 2017 - 2031 14.7.1. China 14.7.2. Japan 14.7.3. India 14.7.4. Australia & New Zealand 14.7.5. Rest of Asia Pacific 14.8. Market Attractiveness Analysis 14.8.1. by Source 14.8.2. by Type 14.8.3. by Functionality 14.8.4. by Application 14.8.5. by End-user 14.8.6. by Country/Sub-region 15. Latin America Empty Capsules Market Analysis and Forecast 15.1. Introduction 15.1.1. Key Findings 15.2. Market Value Forecast by Source, 2017 - 2031 15.2.1. Porcine 15.2.2. Bovine 15.2.3. Marine 15.2.4. Natural 15.3. Market Value Forecast by Type, 2017 - 2031 15.3.1. Gelatin Capsules 15.3.1.1. Hard Gelatin Capsules 15.3.1.2. Soft Gelatin Capsules 15.3.2. Non-gelatin Capsules 15.4. Market Value Forecast by Functionality, 2017 - 2031 15.4.1. Immediate Release 15.4.2. Sustained Release 15.4.3. Delayed Release 15.5. Market Value Forecast by Application, 2017 - 2031 15.5.1. Antibiotic & Antibacterial Drugs 15.5.2. Dietary Supplements 15.5.3. Antacid & Antiflatulent Preparations 15.5.4. Cardiovascular Therapy Drugs 15.5.5. Cough & Cold Drugs 15.5.6. Others (Antianemic Preparations, Anti-inflammatory Drugs, etc.) 15.6. Market Value Forecast by End-user, 2017 - 2031 15.6.1. Pharmaceutical & Biopharmaceutical Companies 15.6.2. Nutraceutical Companies 15.6.3. Others 15.7. Market Value Forecast by Country/Sub-region, 2017 - 2031 15.7.1. Brazil 15.7.2. Mexico 15.7.3. Rest of Latin America 15.8. Market Attractiveness Analysis 15.8.1. by Source 15.8.2. by Type 15.8.3. by Functionality 15.8.4. by Application 15.8.5. by End-user 15.8.6. by Country/Sub-region 16. Middle East & Africa Empty Capsules Market Analysis and Forecast 16.1. Introduction 16.1.1. Key Findings 16.2. Market Value Forecast by Source, 2017 - 2031 16.2.1. Porcine 16.2.2. Bovine 16.2.3. Marine 16.2.4. Natural 16.3. Market Value Forecast by Type, 2017 - 2031 16.3.1. Gelatin Capsules 16.3.1.1. Hard Gelatin Capsules 16.3.1.2. Soft Gelatin Capsules 16.3.2. Non-gelatin Capsules 16.4. Market Value Forecast by Functionality, 2017 - 2031 16.4.1. Immediate Release 16.4.2. Sustained Release 16.4.3. Delayed Release 16.5. Market Value Forecast by Application, 2017 - 2031 16.5.1. Antibiotic & Antibacterial Drugs 16.5.2. Dietary Supplements 16.5.3. Antacid & Antiflatulent Preparations 16.5.4. Cardiovascular Therapy Drugs 16.5.5. Cough & Cold Drugs 16.5.6. Others (Antianemic Preparations, Anti-inflammatory Drugs, etc.) 16.6. Market Value Forecast by End-user, 2017 - 2031 16.6.1. Pharmaceutical & Biopharmaceutical Companies 16.6.2. Nutraceutical Companies 16.6.3. Others 16.7. Market Value Forecast by Country/Sub-region, 2017 - 2031 16.7.1. GCC Countries 16.7.2. South Africa 16.7.3. Rest of Middle East & Africa 16.8. Market Attractiveness Analysis 16.8.1. by Source 16.8.2. by Type 16.8.3. by Functionality 16.8.4. by Application 16.8.5. by End-user 16.8.6. by Country/Sub-region 17. Competition Landscape 17.1. Market Player - Competition Matrix (by Tier and Size of companies) 17.2. Market Share Analysis by Company (2022) 17.3. Company Profiles 17.3.1. ACG 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.1.2. Product Portfolio 17.3.1.3. Financial Overview 17.3.1.4. SWOT Analysis 17.3.1.5. Strategic Overview 17.3.2. Lonza Group Ltd. 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.2.2. Product Portfolio 17.3.2.3. Financial Overview 17.3.2.4. SWOT Analysis 17.3.2.5. Strategic Overview 17.3.3. Qualicaps (Mitsubishi Chemical Group Corporation) 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.3.2. Product Portfolio 17.3.3.3. Financial Overview 17.3.3.4. SWOT Analysis 17.3.3.5. Strategic Overview 17.3.4. Seoheung Co., Ltd. 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.4.2. Product Portfolio 17.3.4.3. Financial Overview 17.3.4.4. SWOT Analysis 17.3.4.5. Strategic Overview 17.3.5. The Roxlor Group 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.5.2. Product Portfolio 17.3.5.3. Financial Overview 17.3.5.4. SWOT Analysis 17.3.5.5. Strategic Overview 17.3.6. Nectar Lifesciences Ltd 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.6.2. Product Portfolio 17.3.6.3. Financial Overview 17.3.6.4. SWOT Analysis 17.3.6.5. Strategic Overview 17.3.7. Medi-Caps Ltd. 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.7.2. Product Portfolio 17.3.7.3. Financial Overview 17.3.7.4. SWOT Analysis 17.3.7.5. Strategic Overview 17.3.8. CapsCanada 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.8.2. Product Portfolio 17.3.8.3. Financial Overview 17.3.8.4. SWOT Analysis 17.3.8.5. Strategic Overview 17.3.9. Natural Capsules Limited 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.9.2. Product Portfolio 17.3.9.3. Financial Overview 17.3.9.4. SWOT Analysis 17.3.9.5. Strategic Overview
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
Transparency Market Research社の製薬分野での最新刊レポート
本レポートと同じKEY WORD(analysis size)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |